Update on pharmaceutical and minimally invasive management strategies for chronic obstructive pulmonary disease.

Pulm Med · 2011 · PMC3109340 · PMID 21660228

Europe PMC DOI

hedged sentence

0.0520

closest p · 1.0× alpha

0.0520

boldest claim

The sentences

showed a trendP = .052so close (0.05 < p ≤ 0.1)

However, the combination of fluticasone and salmeterol showed a trend towards a significant ( P = .052) reduction of all-cause mortality by 17.5% in 3 years compared to placebo.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.